Levetiracetam induced toxic epidermal necrolysis: A fatal outcome

Dr. Chhaya Goyal; Mr. Mohammad Rafi

Indian Journal of Pharmacy and Pharmacology

Official Publication of Innovative Education and Scientific Research Foundation

Indian Journal of Pharmacy and Pharmacology

Print ISSN: 2393-9079

Online ISSN: 2393-9087

CODEN : IJPPTK

Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...

Article type

Case Report

Article page

107-109

Authors Details

Dr. Chhaya Goyal, Mr. Mohammad Rafi

View Article As

Downlaod Files

Bookmark article

Article Indexing

Citation Managers

Download Citation

Article statistics

Viewed: 1590

PDF Downloaded: 674

Levetiracetam induced toxic epidermal necrolysis: A fatal outcome

Case Report

Author Details : Dr. Chhaya Goyal, Mr. Mohammad Rafi

Volume : 1, Issue : 1, Year : 2014

Article Page : 107-109

Suggest article by email

Get Permission

Abstract

Toxic Epidermal Necrolysis (TEN) is a rare, life-threatening dermatological manifestation which usually develops after intake of some culprit drugs. These drugs often belong to antibiotics, sulfonamides, non-steroidal anti-inflammatory drugs (NSAIDs) and anti-convulsants. We here report a fatal case of an elderly male patient who developed TEN soon after the intake of levetiracetam.

How to cite : Goyal D C, Rafi M M, Levetiracetam induced toxic epidermal necrolysis: A fatal outcome. Indian J Pharm Pharmacol 2014;1(1):107-109

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.